Image_6_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

“…Here, we characterize the putative endocrine fate and replicative status of these newly formed cells.…”

Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study by Noriah Maraba (4720794)

“…Initial loss to follow-up (ILFU), defined as not starting on TB treatment within 28 days of testing positive, is undermining control efforts. We assessed the feasibility, acceptability, and potential of a mHealth application to reduce ILFU.…”

Table_1_Intraoperative Fractions of Inspiratory Oxygen Are Associated With Recurrence-Free Survival After Elective Cancer Surgery.docx by Sarah Dehne (668415)

“…The hazard for the primary outcome decreased by 3.5% with every 1% increase in FiO₂. …”

Image_2_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

“…Here, we characterize the putative endocrine fate and replicative status of these newly formed cells.…”

DataSheet1_The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis.pdf by Zaiwei Song (11590222)

“…Meta-analysis was conducted by using Cochrane Collaboration Review Manager software 5.3. The odds ratios (ORs) or hazard ratios (HRs) with 95% confidence interval (95% CI) were analyzed to evaluate the associations between SNPs and clinical outcomes. …”

Image_8_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

“…Here, we characterize the putative endocrine fate and replicative status of these newly formed cells.…”

DataSheet3_The systematic review and meta-analysis evaluated the efficacy and safety of nefopam for catheter-related bladder discomfort based on randomized controlled trials.PDF by Junpeng Chi (17445264)

“…Data analysis was performed using RevMan version 5.4.1.</p><p>Results: Five RCTs with 405 patients were analyzed to evaluate the efficacy of nefopam on postoperative CRBD. …”

Image_3_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

“…Here, we characterize the putative endocrine fate and replicative status of these newly formed cells.…”

datasheet2_Pirfenidone Is a Vasodilator: Involvement of KV7 Channels in the Effect on Endothelium-Dependent Vasodilatation in Type-2 Diabetic Mice.pdf by Lilliana Beck (9014447)

“…Immunoblotting for K_V7.4, K_V7.5, and BK_Ca channel subunits were unaltered in aorta from db/db mice. …”

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1 by Arianna Marini (4275988)

“…We generated isogenic NOMV-producing meningococcal strains from an African serogroup W isolate, each over-expressing one of four fHbp variant group 1 sequences (ID 1, 5, 9, or 74), including those most common among invasive African meningococcal isolates. …”

Data_Sheet_1_Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study.pdf by Farzad Hadaegh (305376)

“…Moreover, intermediate and ideal categories of CVH metrics were associated with lower risk for different CVD outcomes, i.e., 44 (0.56, 0.48–0.65) and 76% (0.24, 0.17–0.35) for CVD; 43 (0.57, 0.47–0.67) and 75% (0.25, 0.16–0.37) for CHD, 58 (0.42, 0.29–0.61) and 86% (0.14, 0.04–0.44) for stroke; 56 (0.44, 0.29–0.66) and 55% (0.45, 0.21–0.99) for sudden death; and 25 (0.75, 0.62–0.90) and 46% (0.54, 0.37–0.80) for all-cause mortality events, respectively. We also assessed the impact of changes in ideal CVH status from phase III to phase IV (2008–2011) on CVD events among 5,666 participants. …”

Table_1_Automated closed–loop FiO2 titration increases the percentage of time spent in optimal zones of oxygen saturation in pediatric patients–A randomized crossover clinical tria... by Ekin Soydan (13386903)

“…The percentage of time spent in acceptable, suboptimal and unacceptable zones decreased. Findings were similar with the use of closed-loop FiO₂ controller compared to manual titration in patients with ARDS [95.9 (81.6–98.8) vs. 78 (49.5–94.8) %; P = 0.027]. …”

The Role of <i>TLR4</i> 896 A><i>G</i> and 1196 C><i>T</i> in Susceptibility to Infections: A Review and Meta-Analysis of Genetic Association Studies by Panayiotis D. Ziakas (464048)

“…</p> <p>Data Sources</p><p>We searched PubMed and EMBASE up to March 2013 for pertinent literature in English, and complemented search with references lists of eligible studies.…”

Image_9_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

“…Here, we characterize the putative endocrine fate and replicative status of these newly formed cells.…”

Data Sheet 2_Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles.... by Ettore Silvagni (9576002)

“…</p>Results<p>We identified 7,541 therapeutic courses in 5,563 patients: 2,343 started as TNFi users, 1,443 as JAKi users, and 1,777 started with other drugs (1,459 days of follow-up). …”

Table_1_Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.docx by Laura Bonanno (3524183)

“…Median PFS of the overall study population was 4.8 months (95% confidence interval [95% CI]: 4.4-5.4), median OS was 7.1 months (95% CI: 6.3-7.7). …”

Image_2_Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.jpeg by Laura Bonanno (3524183)

“…Median PFS of the overall study population was 4.8 months (95% confidence interval [95% CI]: 4.4-5.4), median OS was 7.1 months (95% CI: 6.3-7.7). …”

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Sylvia Haas (414005)

“…Taking TTR as a measure of the quality of patient management, we analysed its relationship with 1-year outcomes, including stroke/systemic embolism (SE), major bleeding, and all-cause mortality.…”

Image_1_Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.jpeg by Laura Bonanno (3524183)

“…Median PFS of the overall study population was 4.8 months (95% confidence interval [95% CI]: 4.4-5.4), median OS was 7.1 months (95% CI: 6.3-7.7). …”

DataSheet1_The systematic review and meta-analysis evaluated the efficacy and safety of nefopam for catheter-related bladder discomfort based on randomized controlled trials.PDF by Junpeng Chi (17445264)

“…Data analysis was performed using RevMan version 5.4.1.</p><p>Results: Five RCTs with 405 patients were analyzed to evaluate the efficacy of nefopam on postoperative CRBD. …”